Related Experiment Videos
Thioacetamide-induced changes in hepatic hexokinase isoenzymes
G M Lawrence1, A C Beesley, M A Jepson
1School of Life Sciences, Leicester Polytechnic, United Kingdom.
Toxicology
|September 1, 1989
Summary
Thioacetamide injection alters liver enzyme activity by damaging specific cells and causing inflammation. Enzyme levels normalize as liver cells regenerate and inflammation subsides, indicating cell population changes, not gene expression shifts.
Area of Science:
- Biochemistry
- Hepatology
- Toxicology
Background:
- Hexokinase activity in the liver is crucial for glucose metabolism, with distinct low-Km and high-Km isoforms.
- Glucokinase (high-Km hexokinase) is primarily located in perivenous hepatocytes, making it vulnerable to toxins.
- Thioacetamide is a known hepatotoxin used to induce liver injury in experimental models.
Purpose of the Study:
- To investigate the dynamic changes in low-Km hexokinase and high-Km glucokinase activities in the liver following thioacetamide-induced injury.
- To determine whether observed enzyme activity alterations are due to changes in gene expression or shifts in liver cell populations.
Main Methods:
- Rats were administered a single intraperitoneal injection of thioacetamide (200 mg/kg body weight).
- Liver samples were analyzed at various time points (up to 48 hours and 10 days) post-injection.
- Hexokinase and glucokinase activities (low-Km and high-Km) were measured and correlated with histological observations of liver damage and inflammation.
Main Results:
- A progressive increase in low-Km hexokinase activity and a decrease in high-Km glucokinase activity were observed within 48 hours of thioacetamide administration.
- Loss of glucokinase activity was attributed to selective damage of perivenous hepatocytes, where it is predominantly located.
- Increased low-Km hexokinase activity was associated with inflammatory infiltrates in the injured liver regions.
- Both enzyme activities returned to control levels by 10 days, coinciding with the resolution of inflammation and replacement of necrotic hepatocytes.
Conclusions:
- Thioacetamide-induced changes in liver hexokinase and glucokinase activities are primarily driven by alterations in liver cell populations (hepatocyte damage and inflammatory cell infiltration).
- The findings suggest that observed enzyme activity shifts do not reflect changes in gene expression within existing hepatocytes but rather a dynamic response to tissue injury and repair.